A published meta-analysis for BRCA1-related tumors reported a worse outcome among the breast cancer patients carrying a mutated BRCA gene [7], while BRCA1 mutated ovarian cancer patients had a more favorable clinical outcome [9]. This evidence concerns the gene BRCA1 and ovarian cancer.